Canary Medical announced today that it completed the first-in-human limited feasibility trial of its cardiac auscultation monitoring device. Vancouver, British Columbia–based Canary is developing the device as a first-in-class implantable sensor. It provides daily adjunctive objective cardiac parameter measurements. The company believes it could enable patients and clinicians to better manage congestive heart failure symptoms. […]
Implants
Smith+Nephew unveils expanded sports medicine portfolio
Smith+Nephew today announced plans to unveil new sports medicine technologies this week. The London-based orthopedic giant plans to premiere its newly acquired CartiHeal Agili-C cartilage repair implant. Bioventus had a deal in place to acquire CartiHeal and its technology last summer. However, when that fell through, Smith+Nephew executed a $180 million buyout (with a potential […]
Think Surgical, Link collab on surgical robotics for total knee replacement
Think Surgical announced today that it plans a collaboration with Waldemar Link to implement its technology in surgical robotics. In the collaboration, Think Surgical plans to add the LinkSymphoKnee system to its ID-HUB. ID-HUB serves as a proprietary data bank of implant modules for use with Think Surgical’s TMINI handheld miniature surgical robotic system. TMINI […]
Senseonics earns expanded Medicare coverage for long-term implantable CGM
Senseonics (NYSE:SENS) and Ascensia Diabetes Care today announced expanded Medicare coverage for the Eversense E3 CGM system. Medicare implemented Local Coverage Determinations (LCDs) providing access to implantable CGM for basal-only patients. It significantly expands access to Senseonics’ long-term (six months) implantable glucose monitor. The expansion for implantable CGMs includes all people with diabetes using insulin. […]
Zimmer Biomet beats Street in Q4, reduces headcount in restructuring effort
Zimmer Biomet shares are down despite fourth-quarter results that topped the consensus forecast. The Warsaw, Indiana–based orthopedics device company is shedding hundreds of jobs in a new round of restructuring. Mike Matson, senior research analyst at Needham & Co., noted ZB’s Street-beating Q4 and its above-consensus 2024 projections. Still, the company has been losing share […]
Exactech, Statera partner on world’s first smart reverse shoulder implant
Exactech announced today that it partnered with Statera Medical to design the world’s first smart reverse shoulder implant. The companies plan to co-develop the new implant over the next few years. Samuel Bourdon, Statera’s CEO, said in a news release that the company developed its Goldilocks smart implant technology to give surgeons more precision. These […]
Inspire Medical stock falls despite 40% Q4 sales growth, Wall Street beats
Inspire Medical Systems (NYSE:INSP) shares took a hit today despite fourth-quarter results that beat the consensus forecast. Shares of INSP fell nearly 7% at $210.35 apiece in midday trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — stayed even. The Minneapolis-based maker of neuromodulation implants for […]
ShiraTronics completes implantable migraine therapy pilot enrollment, sets up U.S. clinical study
ShiraTronics announced that it completed enrollment in a pilot study of its minimally invasive implantable migraine therapy. Minneapolis-based ShiraTronics designed its neuromodulation system to address the debilitating symptoms of migraines. The company says it offers the first-ever fully implantable system for head location utilizing a minimally invasive approach. The fully implantable, programmable device delivers precise […]
Former Tandem CCO joins Ascensia as president of CGM
Ascensia Diabetes Care parent company PHC Holdings and Senseonics announced today that Ascensia named Brian Hansen its president of CGM. Hansen’s appointment to the newly created role at the global distributor of Senseonics’ Eversense CGM went into effect today, Feb. 6. Responsibilities for Hansen include the global commercialization and growth of the Eversense system. The fully […]
FDA expands approval for Boston Scientific spinal cord stim to include chronic back pain without prior back surgery
Boston Scientific announced today that the FDA approved an expanded indication for its WaveWriter spinal cord stimulation (SCS) systems. The indication covers chronic low back and leg pain in people without prior back surgery — called non-surgical back pain (NSBP). Boston Scientific says first-line treatment for people with chronic back pain tends to have limitations. […]
Inspire Medical CEO takes over as board chair
Inspire Medical Systems (NYSE:INSP) announced today that Marilyn Carlson Nelson retired as chair of the company’s board of directors. The Minneapolis-based sleep apnea treatment developer appointed current CEO Timothy Herbert to the additional role of board chair. Herbert’s appointment goes into effect after the company’s annual meeting of stockholders on May 2, 2024. Nelson became […]